Daniel I Resnicow

age ~45

from Waltham, MA

Get Report

Also known as:

Daniel Ilan Resnicow
Daniel Rosen
Daniel Resincow
Daniel W

Phone and address:: 56 Summit St, Waltham, MA 02451
303 579-2987

Connected to:

Daniel Resnicow Phones & Addresses

56 Summit St, Waltham, MA 02451 • 303 579-2987
Somerville, MA
71 Washington St, New York, NY 10011
2954 Shady Holw W, Boulder, CO 80304
4701 Iselin Ave, Bronx, NY 10471
San Diego, CA

Work

Company:

X-chem, inc.
Apr 2016 to Mar 2018
Position:

Associate director, business development

Education

Degree:

Doctorates, Doctor of Philosophy
School / High School:

University of Colorado Boulder
2001 to 2007
Specialities:

Biology

Skills

Protein Chemistry • Protein Purification • Biochemistry • Molecular Biology • Biotechnology • Drug Discovery • Purification • Lifesciences • Cell Biology • Cell Culture • Pcr • Sds Page • Genetics • Cell • Molecular Cloning • Elisa • Genomics • Dna • Business Development • Term Sheets • Contract Negotiation • Hplc • Qpcr • Proteomics • Medicinal Chemistry • Microbiology • Pharmaceutical Industry • Drug Development • Technology Transfer • Research and Development

Languages

English

Industries

Biotechnology

Us Patents

Aptamers To 4-1Bb And Their Use In Treating Diseases And Disorders
view source
US Patent:

20120322862, Dec 20, 2012
Filed:

Mar 3, 2011
Appl. No.:

13/582332
Inventors:

Jonathan Vaught - Boulder CO, US
Daniel I. Resnicow - Boulder CO, US
Sheela Waugh - Erie CO, US
Sheri K. Wilcox - Longmont CO, US
Daniel J. Schneider - Arvada CO, US
Assignee:

SOMALOGIC, INC. - Boulder CO
International Classification:

A61K 31/7115
A61P 31/00
A61P 37/08
C07H 21/02
A61P 25/00
US Classification:

514 44 R, 536 231
Abstract:

The present disclosure relates generally to the field of nucleic acids and, more particularly, to aptamers capable of binding to 4-1BB; pharmaceutical compositions comprising such 4-1BB aptamers; and methods of making and using the same.

Aptamers To Beta-Ngf And Their Use In Treating Beta-Ngf Mediated Diseases And Disorders
view source
US Patent:

20130012693, Jan 10, 2013
Filed:

Apr 12, 2011
Appl. No.:

13/634618
Inventors:

Daniel J. Schneider - Arvada CO, US
Akihiko Hisaminato - Osaka, JP
Sheela Waugh - Erie CO, US
Daniel Resnicow - Boulder CO, US
Akira Nagabukuro - Osaka, JP
Toshihide Ono - Osaka, JP
Assignee:

OTSUKA PHARMACEUTICAL CO., LTD. - Tokyo
SOMALOGIC, INC. - Boulder CO
International Classification:

C07H 21/04
US Classification:

536 231
Abstract:

The present disclosure relates generally to the field of nucleic acids and, more particularly, to aptamers capable of binding to β-NGF; pharmaceutical compositions comprising such β-NGF aptamers; and methods of making and using the same.

Aptamers To 4-1Bb And Their Use In Treating Diseases And Disorders
view source
US Patent:

20140081011, Mar 20, 2014
Filed:

Nov 19, 2013
Appl. No.:

14/084411
Inventors:

Daniel I. Resnicow - Boulder CO, US
Sheela Waugh - Erie CO, US
Sheri K. Wilcox - Longmont CO, US
Daniel J. Schneider - Arvada CO, US
Assignee:

SOMALOGIC, INC. - Boulder CO
International Classification:

C12N 15/115
US Classification:

536 231
Abstract:

The present disclosure relates generally to the field of nucleic acids and, more particularly, to aptamers capable of binding to 4-1BB; pharmaceutical compositions comprising such 4-1BB aptamers; and methods of making and using the same.

Resumes

Daniel Resnicow

view source

Location:

31 Harold St, Somerville, MA 02143

Industry:

Biotechnology

Work:

X-Chem, Inc. Apr 2016 - Mar 2018
Associate Director, Business Development
Somalogic Feb 2011 - Jun 2011
Scientist Ii
Somalogic May 2008 - Feb 2011
Scientist

Education:

University of Colorado Boulder 2001 - 2007
Doctorates, Doctor of Philosophy, Biology Brandeis University 1997 - 2001
Bachelors, Bachelor of Science, Biology

Skills:

Protein Chemistry
Protein Purification
Biochemistry
Molecular Biology
Biotechnology
Drug Discovery
Purification
Lifesciences
Cell Biology
Cell Culture
Pcr
Sds Page
Genetics
Cell
Molecular Cloning
Elisa
Genomics
Dna
Business Development
Term Sheets
Contract Negotiation
Hplc
Qpcr
Proteomics
Medicinal Chemistry
Microbiology
Pharmaceutical Industry
Drug Development
Technology Transfer
Research and Development

Languages:

English